Ten reasons why A1C should not be used as a screening tool for T2DM
Screening of a disease can be understood as detecting a disease in an individual before clinical symptoms are apparent. In case of diabetes mellitus, as of now, the preferred screening test is still fasting blood sugar (FBS). Glycated hemoglobin (A1C) however, did make its way into guidelines as a d...
Saved in:
Main Author: | Shahar, Mohammad Arif |
---|---|
Format: | Conference or Workshop Item |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/58564/1/Debate%20HbA1C.pdf http://irep.iium.edu.my/58564/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evidence based guidelines. Diagnosis and management of Guillain-Barre syndrome in ten steps
by: Leonhard, Sonja E., et al.
Published: (2021) -
Who should be screened for primary aldosteronism? A comprehensive review of current evidence
by: Huang, Wei Chieh, et al.
Published: (2022) -
Ten years review of cancer bladder in Hospital Universiti Sains Malaysia, Kubang Kerian
by: Almotawakel, Ahmed Ali Abdullah
Published: (2006) -
What elements of sport and exercise science should primary care physicians learn? an interdisciplinary discussion
by: Wattanapisit, Apichai, et al.
Published: (2021) -
TrueDx TSH assay is an acceptable screening test for both hypo- and hyperthyroidism in the general population: correlation between trueDx TSH assay and the standard 3rd Generation TSH Chemoluminiscence Immunoassay (CMIA)
by: Shahar, Mohammad Arif, et al.
Published: (2017)